In the News

Triangle Business Journal and accounting giant BDO have honored Clinipace with one of its inaugural Life Sciences Awards.  The Life Sciences awards recognize both individuals and research organizations that are breaking ground in this field.

US officials' new take on import rules may mean APIs destined for trials will only be allowed into the country if they are listed in an effective IND application, according to Clinipace QA chief Nikolas Burlew.

Clinipace Worldwide, a global digital contract research organization (dCRO), has expanded Ran Frenkel, R.Ph, VP, international business development, role at the company. Mr. Frenkel has taken on the additional responsibility as managing director, EMEA. Country managers in the region report directly to him in his new role (page 84).

There are some lessons that no amount of reading can teach an entrepreneur. Sometimes, you just have to learn by doing. And that goes for companies at all stages, as a panel of CEOs at the CED Life Science Conference

Jeff Williams, Chief Executive Officer at Clinipace Worldwide, talks to The Skinny about his company's emergence as a member of Forbes' "Nifty 50" - the most promising privately held companies in the country.

Clinipace ranks #36 in this year's prestigious list of America’s 100 Most Promising Companies.

Clinipace has revamped its eClinical data platform, TEMPO, saying its new offering rolls disparate IT applications into one, allowing clients to cut down the cost and complexity of their clinical trials.  TEMPO is now outfitted with configurable modules, the CRO says, a set of predefined workflows, forms and reports bundled as a unit within one database.

Clinipace Worldwide, a digital contract research organization (dCRO), today announced innovations to its proprietary TEMPOeClinical platform. As a private cloud-based application, TEMPO aims to serve as the technology foundation to all of Clinipace’s clinical development service delivery teams.

The buzz at the J.P. Morgan Healthcare Conference in San Francisco this year was palpable at the Westin, emanating outward to the dozens of other hotels, restaurants, bars and outdoor venues where meetings between dealmakers, analysts, executives and many others were taking place. FierceMarkets caught up with Clinipace CEO Jeff Williams and President and General Counsel Chris Porter (slide #34)

Clinipace has been honored with a Triangle Business Journal 2012 Fast 50 Award, which showcases the fastest-growing private companies in the Raleigh-Durham area.  Clinipace ranked #18 on this year's list.